[Effect of blood transfusion on specific anti-tetanus immunity]

The clinical and experimental studies have demonstrated that in patients with large lesions accompanied by blood loss, injection of heterogenous antitetanic blood serum may be withdrawn during emergency prophylaxis of tetanus provided these patients are administered hemotherapy. Such a treatment policy makes it possible to considerably reduce the incidence of allergic complications that may occur after injection of antitetanic horse serum.